Your browser has either disabled or does not support javascript. Javascript is required for full website experience.
Castle Biosciences Inc.
CSTL
$
50.81
14%
Thu November 12th, 2020
13:50
Press Releases
Analysis
Zacks.com featured highlights include: Catalyst Biosciences, UFP Industries, VeriSign, InMode and Castle Biosciences
Zacks
Tue November 10th, 2020
18:29
Earnings
Analysis
Castle Biosciences, Inc. 2020 Q3 - Results - Earnings Call Presentation
Seeking Alpha
04:57
Earnings
Analysis
Castle Biosciences, Inc. (CSTL) CEO Derek Maetzold on Q3 2020 Results - Earnings Call Transcript
Seeking Alpha
Mon October 19th, 2020
16:32
Press Releases
Analysis
Zacks.com featured highlights include: Daqo, Surface Oncology, Covenant, Herc and Castle Biosciences
Zacks
Fri September 25th, 2020
10:43
Analysis
Castle Biosciences stock price target raised to $57 from $50 at SVB Leerink
MarketWatch
Tue August 11th, 2020
04:54
Earnings
Analysis
Castle Biosciences, Inc.'s (CSTL) CEO Derek Maetzold on Q2 2020 Results - Earnings Call Transcript
Seeking Alpha
Mon August 10th, 2020
22:25
Analysis
Castle Biosciences, Inc. (CSTL) Reports Q2 Loss, Tops Revenue Estimates
Zacks
22:00
Earnings
Analysis
Castle Biosciences, Inc. 2020 Q2 - Results - Earnings Call Presentation
Seeking Alpha
Mon August 3rd, 2020
16:31
Earnings
Analysis
Castle Biosciences, Inc. (CSTL) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Zacks
